Location: Home
  • search
  • go
  • Relate News
  • 3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine
  • 3/25/2021The Supreme Court Issued A Judicial Interpretation on Punitive Damages...
  • 3/25/2021CNIPA to Take on More Roles On Adjudicating Drug Patent Disputes?
  • 3/24/2021Pharma Manufacturing Industry Lag and Potential for China's Five-Year ...
  • 3/24/2021Hong Kong Halts Pfizer/BioNTech COVID-19 Vaccines, Citing Packaging Is...
  • 3/24/2021Frontier to Market China's First Anti-HIV Drug Globally
  • 3/24/2021China Approves Clinical Trials for Livzon Pharma Unit's COVID-19 Vacci...
  • 3/24/2021Blueprint/CStone Granted Chinese Approval of GAVRETO(R) (pralsetinib) ...
  • 3/24/2021HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combo with Ti...
  • 3/24/2021China Approves Inhaled CanSino Vaccine for Clinical Trials
  • 3/24/2021Brii Bio Raises $155M in Round C Financing
  • 3/24/2021Zenas Biopharma Debuts to Develop Immune-based Therapies
  • 3/24/2021Women's Cancers in China: A Spatio-temporal Epidemiology Analysis
  • 3/24/2021China Declares Early Success in Expanding Online Medical Services
  • 3/24/2021BMS to Offer Steeper Discount for Opdivo in China, Cutting Price to ...
  • 3/24/2021Pharma Research Products Granted Chinse Patent for Hyaluronic Acid Dec...
  • 3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M
  • 3/24/2021Hainan's Lecheng Pilot Zone Launches Insurance to Cover Innovative New...
  • 3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...
  • 3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...
  • 3/23/2021Regencell Bioscience Files for An $18M US IPO
  • 3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...
  • 3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...
  • 3/23/2021Citrine Granted Clinical Trial Waiver for Narcolepsy Drug Wakix and ...
  • 3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations
  • 3/23/2021Everest Med Files NDA for cIAI Drug Xerava (Eravacycline) in China
  • 3/23/2021NMPA Revises Packages Insert of Systemic Quinolone Drugs
  • 3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor
  • 3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report
  • 3/23/2021Review of Chinese CDE-Accepted Drug Registration Applications in 2020
  • Page:220/801 Total number of articles:24010: [First][<<] [218] [219] [220] [221] [222] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group